Pei‐Ling Hsu
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Connective Tissue Growth Factor Research 4
- Ubiquitin and proteasome pathways 3
- Immunology 22
- T-cell and Retrovirus Studies 5
- Immune Cell Function and Interaction 4
- Co-authors
- Su-Ming Hsu (11 shared papers)S M Hsu (5 shared papers)Shaw‐Jenq Tsai (7 shared papers)Arthur Landy (2 shared papers)Wilma Ross (2 shared papers)Su-Su Xie (8 shared papers)Fan‐E Mo (6 shared papers)Shih‐Chieh Lin (3 shared papers)
- Journals
- Human Pathology (4 papers)Journal of Biomedical Science (4 papers)Proceedings of the National Academy of Sciences (2 papers)JNCI Journal of the National Cancer Institute (2 papers)Infection and Immunity (2 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Pei‐Ling Hsu
74 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 136
- Immunology 451
- Pathology and Forensic Medicine 345
- Oncology 342
- Microbiology 72
- Cancer Research 157
Countries citing papers authored by Pei‐Ling Hsu
This map shows the geographic impact of Pei‐Ling Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Ling Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Ling Hsu more than expected).
Fields of papers citing papers by Pei‐Ling Hsu
This network shows the impact of papers produced by Pei‐Ling Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Ling Hsu. The network helps show where Pei‐Ling Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei‐Ling Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 192 | |
| 2 | 1980 | 131 | |
| 3 | Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. | 1992 | 111 |
| 4 | 1993 | 107 | |
| 5 | 1997 | 68 | |
| 6 | 2019 | 61 | |
| 7 | Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease. | 1998 | 55 |
| 8 | 2020 | 53 | |
| 9 | 1981 | 48 | |
| 10 | 2017 | 46 | |
| 11 | 1993 | 45 | |
| 12 | Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells? | 1989 | 45 |
| 13 | 1980 | 44 | |
| 14 | 1989 | 43 | |
| 15 | 2022 | 41 | |
| 16 | 2020 | 39 | |
| 17 | 1982 | 39 | |
| 18 | Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis. | 1991 | 38 |
| 19 | Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. | 1992 | 37 |
| 20 | 2000 | 35 |
About Pei‐Ling Hsu
Pei‐Ling Hsu is a scholar working on Molecular Biology, Immunology, Oncology, Pathology and Forensic Medicine and Physiology, having authored 78 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), T-cell and Retrovirus Studies (5 papers), Glycosylation and Glycoproteins Research (4 papers), Viral-associated cancers and disorders (4 papers), Immune Cell Function and Interaction (4 papers), Connective Tissue Growth Factor Research (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Immunology (451 citations), Pathology and Forensic Medicine (345 citations), Oncology (342 citations), Microbiology (72 citations) and Cancer Research (157 citations). Pei‐Ling Hsu has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Su-Ming Hsu, S M Hsu, S M Hsu, Shaw‐Jenq Tsai, Arthur Landy, Wilma Ross, Su-Su Xie, Fan‐E Mo, Shih‐Chieh Lin and Wen‐Tai Chiu. Their work appears in journals such as Human Pathology, Journal of Biomedical Science, Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.